¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"citrate phosphate dextrose solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • balanced salt solution
    ÆòÇü¿°¾×
  • bromine solution
    ºê·Ò¿ë¾×
  • buffer solution
    ¿ÏÃæ¾×
  • Burow¡¯s solution
    ºÎ·Î¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×
  • crystalloid solution
    °áÁ¤Áú¿ë¾×
  • culture solution
    ¹è¾ç¾×
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×
  • disclosing solution
    1. Ä¡ÅÂÂø»ö¾× 2. ³ëÃâ¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
  • hypotonic solution
    ÀúÀå¾×
  • heavy solution
    Áß¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cardioplegic solution
    ½ÉÀåÁ¤Áö¾×, ½ÉÀ帶ºñ¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×, ±³Áú¿ë¾×
  • conjugate solution
    ¦¿ë¾×
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×
  • equimolecular solution
    µîºÐÀÚ¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • heavy solution
    Áß¾×
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×, ³ôÀº»ïÅõ¾Ð¿ë¾×
  • hypertonic salt solution
    °íÀå½Ä¿°¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • glucose-6-phosphate dehydrogenase
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀ̵å·ÎÀú³×À̽º
  • glucose-6-phosphate dehydrogenase deficiency
    ±Û·çÄÚ½º-6-ÀλêµðÇÏÀÌ µå·ÎÀú³×À̽º °áÇÌ(Áõ)
  • glycerol phosphate
    Àλê±Û¸®¼¼·Ñ.
  • guaiacol phosphate
    Àλê(ìÝß«)°úÀ̾îÄÝ.
  • high energy phosphate bond
    °í¿¡³ÊÁöÀλ꿰°áÇÕ.
  • histamine acid phosphate
    È÷½ºÅ¸¹Î»ê¼ºÀλ꿰
  • histamine phosphate
    ÀλêÈ÷½ºÅ¸¹Î.
  • phosphate
    Àλ꿰(ìÝß«ç¤).
  • phosphate
    Àλ꿰
  • phosphate buffer
    Àλ꿰¿ÏÃæ¾×
  • phosphate dehydrogenase deficiency
    Àλ꿰ݼö¼ÒÈ¿¼Ò°áÇÌÁõ
  • phosphate diabetes
    Àλ꿰´ç´¢
  • phosphate reabsorption
    Àλ꿰ÀçÈí¼ö
  • potassium dihydrogen phosphate
    ÀλêÀ̼ö¼Ò(ì£â©áÈ)Ä®·ý
  • pyridoxal phosphate
    ÀλêÇǸ®µ¶»ì.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • citrate utilization test
    ±¸¿¬»êÀÌ¿ë½ÃÇè
  • desoxycholate citrate agar
    µ¥¿Á½ÃÄÝ»ê ½ÃÆ®¸£»ê ÇÑõ(¡­ß«ùÎô¸).
  • disodium citrate
    ½ÃÆ®¸£»êÀ̳ªÆ®·ý.
  • effervescent lithium citrate
    ºñµî½ÃÆ®¸£»ê¿°¸®Æ¬.
  • simmons citrate agar
    ½Ã¸ó½º±¸¿¬»êÇÑõ
  • thiosulfate citrate
    ±¸¿¬»ê¿°Æ¼¿À¼³ÆäÀÌÆ®
  • thiosulfate citrate bile salt
    Ƽ¿À¼³ÆäÀÌÆ®½ÃÀÌÆ®·¹ÀÌÆ®´ãÁó»ê¿°
  • tripelennamine citrate
    ½ÃÆ®¸£»êÆ®¸®Æç·» ¾Æ¹Î.
  • trisodium citrate
    »ï³ªÆ®·ý±¸¿¬»ê¿°
  • alkaline phosphate
    ¾ËÄ®¸®¼º Àλ꿰.
  • ammonium magnesium phosphate crystal
    Àλê¾Ï¸ð´½¸¶±×³×½·°áÁ¤
  • calcium hydrogen phosphate crystal
    ¼ö¼ÒÀλêÄ®½·°áÁ¤
  • calcium phosphate
    ÀλêÄ®½·
  • calcium phosphate stone
    Àλê Ä®½·¼®
  • calcium/phosphate metabolism
    Ä®½·/Àλ꿰 ´ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Denhart's solution
    µ§Çϸ£Æ® ¿ë¾×(éÁäû)
  • dilute solution
    Èñ¼®¿ë¾×(ýüà·éÁäû)
  • formal solution
    Æ÷¸£¸» ¿ë¾×(éÁäû)
  • Huebl's iodine solution
    ÈÖºí ¿ä¿Àµå¿ë¾×(éÁäû)
  • hypertonic solution
    °íÀå¾×(ÍÔíåäû)
  • hypotonic solution
    ÀúÀå¾×(î¸íåäû)
  • ideal solution
    ÀÌ»ó ¿ë¾×(×âßÌéÁäû)
  • isoosmolar solution
    µîÀå¾×(Ôõíåäû)
  • isosmotic solution
    µî»ïÅõ¾×(Ôõß¶÷âäû)
  • isotonic solution
    µîÀå¾×(Ôõíåäû)
  • Knop's solution
    Å©³ô¿ë¾×(éÁäû)
  • Krebs-Ringer solution
    Å©·¾½º-¸µ°Å ¿ë¾×(éÁäû)
  • Locke's solution
    ·Ï ¿ë¾×(éÁäû)
  • Lugol's solution
    ·ç°ñ ¿ë¾×(éÁäû)
  • molar solution
    ¸ô ¿ë¾×(éÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PD Doctor of Pharmacy; Dublin Pharmacopoeia; interpupillary distance; Paget disease; pancreatic duct; p...
SS disulfide; sacrosciatic; saline soak; saline solution; saliva sample; saliva substitute; Salmonella-...
ACD   1) Absolute Cardiac Dullness; Àý´ë½ÉµÐŹÀ½
  2) Anemia of Chronic Disease
&nbs...
D-5-HS 5% dextrose in Harman's solution
D/LR dextrose in lactated Ringer solution
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PBS I--phosphate buffer solution
PBS phosphate buffered saline solution
PBS phosphate buffered solution
ACL ATP citrate lyase
CIT Citrate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • phosphate
    ÀÎ, Àλ꿰
  • phosphate buffered saline
    Àλ꿰 ½Ä¿°¼ö
  • phosphate depletion
    Àλ꿰 °í°¥
  • sodium phosphate
    ÀÎ»ê ³ªÆ®·ý
    µ¿ÀǾî=disodium hydrogen
  • sodium tertiary phosphate
    Á¦ 3ÀÎ »ê³ªÆ®·ý
    Ca3
  • tricalcium phosphate
    Á¦ 3Ä®½· Àλ꿰
  • zephiran-trisodium phosphate
    Á¦ÇǶõ-Æ®¸®¼Òµð¿ò ÀÎ»ê ¿°
  • zinc phosphate
    ÀÎ»ê ¾Æ¿¬
  • zinc phosphate cement base
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ® ÀÌÀå
    ÀÎ»ê ¾Æ¿¬ ½Ã¸àÆ®¸¦ »ç¿ëÇÏ¿© Ä¡¾Æ¿¡ Çü¼ºÇÑ ¿Íµ¿¿¡ base¸¦ ±î´Â °Í.
  • acetic acid solution
    ¾Æ¼¼Æ® »ê ¿ë¾×
  • alkaline solution
    ¾ËÄ®¸®¼º ¿ë¾×
  • aqueous solution
    ¼ö¾ç ¾×, ¼ö¿ë¾×
    ¿ë¸Å·Î¼­ ¹°ÀÌ »ç¿ëµÇ´Â ¿ë¾×.
  • artificial calcifying solution
    Àΰø ¼®È¸È­ ¾×, Àΰø ¼®È¸È­ ¿ë¾×
  • boric acid solution
    ºØ»ê ¼ö
  • cardioplegic solution
    ½É Á¤Áö ¿ë¾×
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
chlorothen citrate Chloromethapyrilene citrate; N,N-dimethyl-N'-(2-pyridyl)-N'-(5-chloro-2-thenyl)ethylenediamine citrate;an antihistaminic agent.
(05 Mar 2000)
choline dihydrogen citrate <chemical> A lipotropic agent.
Chemical name: (2-hydroxyethyl)trimethylammonium citrate.
(17 Jul 2002)
citrate A salt or ester of citric acid; used as anticoagulants because they bind calcium ions.
(05 Mar 2000)
citrate aldolase Citrate (pro-3S)-lyase;an enzyme that catalyses the cleavage of citrate to oxaloacetate and acetate, in the absence of coenzyme A.
Synonym: citrase, citratase, citrate aldolase, citridesmolase.
(05 Mar 2000)
citrate cleavage enzyme ATP citrate (pro-3S)-lyase
citrate intoxication A toxic condition that may develop during massive replacement therapy with transfused blood that contains citrate as an anticoagulant; the citrate combines with calcium ions and may result in tetany.
(05 Mar 2000)
citrate lyase Citrate (pro-3S)-lyase;an enzyme that catalyses the cleavage of citrate to oxaloacetate and acetate, in the absence of coenzyme A.
Synonym: citrase, citratase, citrate aldolase, citridesmolase.
(05 Mar 2000)
citrate permease <chemical> From lactococcus lactis
(26 Jun 1999)
citrate (pro-3S)-lyase <enzyme> Consists of two enzymes and an acyl carrier protein
Registry number: EC 4.1.3.6
Synonym: citrate lyase
(26 Jun 1999)
citrate (pro-3S)-lyase deacetylase <enzyme> Catalyses conversion of enzymatically active acetyl-s-citrate lyase (4.1.3.6) into inactive hs-form and acetate
Registry number: EC 3.1.2.-
Synonym: citrate lyase deacetylase
(26 Jun 1999)
citrate (pro-3S)-lyase ligase <enzyme> Deacetylcitrate lyase, acetate and ATP forms citrate lyase, AMP, pi
Registry number: EC 6.2.1.22
Synonym: citc gene product, acetate-sh-citrate lyase ligase, citrate lyase ligase
(26 Jun 1999)
citrate (si)-synthase <enzyme> An enzyme of the lyase class that catalyses the condensation of oxaloacetate and the acetyl group of coenzyme a to form citrate and coenzyme a. This is the initial reaction in the tricarboxylic acid cycle.
Chemical name: Citrate oxaloacetate-lyase ((pro-3S)-CH2COO(-)--acetyl-CoA)
Registry number: EC 4.1.3.7
(12 Dec 1998)
citrate synthase Citrate (si)-synthase;an enzyme catalyzing the condensation of oxaloacetate, water, and acetyl-CoA, forming citrate and coenzyme A; an important step in the tricarboxylic acid cycle.
Synonym: citrogenase, condensing enzyme, oxaloacetate transacetase.
(05 Mar 2000)
clomiphene citrate <drug, gynaecology> A fertility drug that stimulates ovulation through the release of gonadotrophins from the pituitary gland.
(13 Nov 1997)
piperazine citrate A vermifuge for pinworms and roundworms.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á